Geron | GERN - Ebit


Geron reported $-10.79M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Amgen USD 3.96B 464M Dec/2025
Bio Techne USD 54.46M 6.8M Dec/2025
Cassava Sciences USD -13.55M 1.69M Dec/2025
Cytokinetics USD -178.37M 11.61M Dec/2025
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Exelixis USD 235.91M 20.45M Dec/2025
Genmab DKK 260M 199M Dec/2025
Geron USD -10.79M 3.1M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
Incyte USD 383.88M 47.44M Dec/2025
MacroGenics USD -12.1M 32.26M Dec/2025
Novartis USD 4.06B 530M Dec/2025
Novavax USD 20.94M 100.32M Dec/2025